Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells

Breast Cancer Research and Treatment

Volumn 117, Issue 2, 2009, Pages 243-251

  Sengupta, Surojeet ^a   Schiff, Rachel ^b   Katzenellenbogen, Benita S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; CXCR4; Estrogen; Estrogen receptor; HER2

Indexed keywords

BETA ACTIN; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GEFITINIB; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLERIXAFOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TUBERIN;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK; RECEPTOR, ERBB-2; RECEPTORS, CXCR4; RECEPTORS, ESTROGEN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 68949092668     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0186-z     Document Type: Article

References (41)

1. A Muller B Homey H Soto N Ge D Catron ME Buchanan 2001 Involvement of chemokine receptors in breast cancer metastasis Nature 410 50 56 10.1038/35065016
2. G Konecny G Pauletti M Pegram M Untch S Dandekar Z Aguilar 2003 Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer J Natl Cancer Inst 95 142 153
3. DJ Slamon GM Clark SG Wong WJ Levin A Ullrich WL McGuire 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 177 182 10.1126/science.3798106
4. D Yu MC Hung 2000 Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 19 6115 6121 10.1038/sj.onc.1203972
5. Y Chen G Stamatoyannopoulos CZ Song 2003 Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro Cancer Res 63 4801 4804
6. N Lapteva AG Yang DE Sanders RW Strube SY Chen 2005 CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo Cancer Gene Ther 12 84 89 10.1038/sj.cgt.7700770
7. MC Smith KE Luker JR Garbow JL Prior E Jackson D Piwnica-Worms 2004 CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 8604 8612 10.1158/0008-5472.CAN-04-1844
8. Z Liang T Wu H Lou X Yu RS Taichman SK Lau 2004 Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4 Cancer Res 64 4302 4308 10.1158/0008-5472.CAN-03-3958
9. Z Liang Y Yoon J Votaw MM Goodman L Williams H Shim 2005 Silencing of CXCR4 blocks breast cancer metastasis Cancer Res 65 967 971
10. Y Kang PM Siegel W Shu M Drobnjak SM Kakonen C Cordon-Cardo 2003 A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 537 549 10.1016/S1535-6108(03)00132-6
11. AJ Minn GP Gupta PM Siegel PD Bos W Shu DD Giri 2005 Genes that mediate breast cancer metastasis to lung Nature 436 518 524 10.1038/nature03799
12. O Salvucci A Bouchard A Baccarelli J Deschenes G Sauter R Simon 2006 The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study Breast Cancer Res Treat 97 275 283 10.1007/s10549-005-9121-8
13. DJ Slamon B Leyland-Jones S Shak H Fuchs V Paton A Bajamonde 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783 792 10.1056/ NEJM200103153441101
14. LD Read D Keith Jr DJ Slamon BS Katzenellenbogen 1990 Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines Cancer Res 50 3947 3951
15. P Lal LK Tan B Chen 2005 Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3, 655 invasive breast carcinomas Am J Clin Pathol 123 541 546 10.1309/YMJ3A83TB39MRUT9
16. CK Osborne J Shou S Massarweh R Schiff 2005 Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer Clin Cancer Res 11 865s 870s
17. CC Benz GK Scott JC Sarup RM Johnson D Tripathy E Coronado 1992 Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu Breast Cancer Res Treat 24 85 95 10.1007/BF01961241
18. YM Li Y Pan Y Wei X Cheng BP Zhou M Tan 2004 Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis Cancer Cell 6 459 469 10.1016/j.ccr.2004.09.027
19. J Frasor JM Danes B Komm KC Chang CR Lyttle BS Katzenellenbogen 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype Endocrinology 144 4562 4574 10.1210/en.2003-0567
20. J Shou S Massarweh CK Osborne AE Wakeling S Ali H Weiss 2004 Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer J Natl Cancer Inst 96 926 935
21. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 402 408
22. E De Clercq 2003 The bicyclam AMD3100 story Nat Rev Drug Discov 2 581 587 10.1038/nrd1134
23. L Ma Z Chen H Erdjument-Bromage P Tempst PP Pandolfi 2005 Phosphorylation and functional inactivation of TSC2 by Erk: implications for tuberous sclerosis and cancer pathogenesis Cell 121 179 193 10.1016/j.cell.2005.02.031
24. MS Berger GW Locher S Saurer WJ Gullick MD Waterfield B Groner 1988 Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading Cancer Res 48 1238 1243
25. FE Gago MA Fanelli DR Ciocca 2006 Co-expression of steroid hormone receptors (estrogen receptor alpha and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy J Steroid Biochem Mol Biol 98 36 40 10.1016/j.jsbmb.2005.07.002
26. JS Carroll CA Meyer J Song W Li TR Geistlinger J Eeckhoute 2006 Genome-wide analysis of estrogen receptor binding sites Nat Genet 38 1289 1297 10.1038/ng1901
27. J Frasor F Stossi JM Danes B Komm CR Lyttle BS Katzenellenbogen 2004 Selective estrogen receptor modulators: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells Cancer Res 64 1522 1533 10.1158/0008-5472.CAN-03-3326
28. KA Green JS Carroll 2007 Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state Nat Rev Cancer 7 713 722 10.1038/nrc2211
29. CY Lin VB Vega JS Thomsen T Zhang SL Kong M Xie 2007 Whole-genome cartography of estrogen receptor alpha binding sites PLoS Genet 3 e87 10.1371/journal.pgen.0030087
30. DH Barnett S Sheng T Howe Charn A Waheed WS Sly C-Y Lin 2008 Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer Cancer Res 68 3505 3515 10.1158/0008-5472.CAN-07-6151
31. BS Katzenellenbogen J Frasor 2004 Therapeutic targeting in the estrogen receptor hormonal pathway Semin Oncol 31 28 38 10.1053/j.seminoncol.2004.01.004
32. WR Harrington SH Kim CC Funk Z Madak-Erdogan R Schiff JA Katzenellenbogen 2006 Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action Mol Endocrinol 20 491 502 10.1210/me.2005-0186
33. Z Madak-Erdogan KJ Kieser SH Kim B Komm JA Katzenellenbogen BS Katzenellenbogen 2008 Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors Mol Endocrinol 22 2116 2127 10.1210/me.2008-0059
34. S Massarweh R Schiff 2007 Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities Clin Cancer Res 13 1950 1954 10.1158/1078-0432.CCR-06-2540
35. CK Osborne R Schiff 2005 Estrogen-receptor biology: continuing progress and therapeutic implications J Clin Oncol 23 1616 1622 10.1200/JCO.2005.10.036
36. RJ Pietras DC Marquez-Garban 2007 Membrane-associated estrogen receptor signaling pathways in human cancers Clin Cancer Res 13 4672 4676 10.1158/1078-0432.CCR-07-1373
37. M Kato J Kitayama S Kazama H Nagawa 2003 Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma Breast Cancer Res 5 R144 R150 10.1186/bcr627
38. RJ Kelleher 3rd A Govindarajan HY Jung H Kang S Tonegawa 2004 Translational control by MAPK signaling in long-term synaptic plasticity and memory Cell 116 467 479 10.1016/S0092-8674(04)00115-1
39. JM Rae MD Johnson JO Scheys KE Cordero JM Larios ME Lippman 2005 GREB1 is a critical regulator of hormone dependent breast cancer growth Breast Cancer Res Treat 92 141 149 10.1007/s10549-005-1483-4
40. A Astrinidis EP Henske 2005 Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease Oncogene 24 7475 7481 10.1038/sj.onc.1209090
41. S Massarweh CK Osborne S Jiang AE Wakeling M Rimawi SK Mohsin 2006 Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer Cancer Res 66 8266 8273 10.1158/0008-5472.CAN-05-4045